How Basic Scientists Help the Pharmaceutical Industry Market Drugs

Adriane Fugh-Berman

PLOS Biology, 2013, vol. 11, issue 11, 1-5

Abstract: : Basic science research is not immune to the influence of pharmaceutical and industrial partners. This Perspective by Adriane Fugh-Bermann explains why scientists should be aware of the potential competing interests posed by practices such as selective publication and ghost-writing.

Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1001716 (text/html)
https://journals.plos.org/plosbiology/article/file ... 01716&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pbio00:1001716

DOI: 10.1371/journal.pbio.1001716

Access Statistics for this article

More articles in PLOS Biology from Public Library of Science
Bibliographic data for series maintained by plosbiology ().